Semine, Josephine .

HRN: 28-22-77  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2025
CEFUROXIME 500MG (TAB)
12/22/2025
12/29/2025
PO
500mg
BID X 7 Days
Thinly MSAF
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: